On May 9, 2025, Catheter Precision, Inc. reported that on May 12, 2025, it entered a Securities Purchase Agreement to sell 1.5 million shares of Series B Convertible Preferred Stock for $1.5 million and issued additional shares in exchange for existing promissory notes, totaling the potential conversion of up to 8,574,000 shares of common stock.